期刊文献+

个体化医疗和大数据时代的机遇和挑战 被引量:27

Challenges and Opportunities of Medicine in the Age of Big Data and Personalized Medicine
暂未订购
导出
摘要 随着分子生物学的发展,高通量测序技术的引入和"大数据"处理能力的提高,现代医学正在经历巨大的变革,由传统的标准化医疗模式向个体化医疗模式转变。随着人类基因组计划和DNA元素百科全书计划的完成及人类和肿瘤基因图谱的绘制,我们正逐步解开人类基因组的奥秘。这极大地推进了人们对疾病,尤其是对肿瘤的认识。作为疾病诊断的"金标准",病理学也在经历着深刻的变革,逐渐向个体化病理学发展。个体化医疗时代的到来,使医学各领域和社会多方面都面临新的机遇和挑战。 Recent advancements of molecular biology, high-throughput sequencing technology and "big data" have a direct impact on medical practice. Medicine is being transformed from the traditional pattern to the new personalized medicine. The human genome project, the encyclopedia of DNA elements project and the atlas of tumor genome project outlined the overall picture of human genome. Our understanding of the nature of diseases, particularly cancer, has made tremendous progress. Pathology, as the foundation of diagnostic medicine, has also been transformed to personalized pathology. The impacts of such developments will affect many aspects of medicine and our lives. We should study and understand this coming revolution and be prepared to take on the challenge.
作者 李静 顾江
出处 《医学与哲学(A)》 北大核心 2014年第1期5-10,25,共7页 Medicine & Philosophy:Humanistic & Social Medicine Edition
关键词 个体化医疗 大数据 第二代测序技术 个体化病理学 靶向治疗 肿瘤异质性 personalized medicine, big data, next-generation sequencing, personalized pathology, targeted therapy, tumor heterogeneity
  • 相关文献

参考文献1

二级参考文献51

  • 1Welch JS, Link DC. Genomics of AML: clinical applications of next-generation sequencing. Hematology Am Soc Hematot Educ Program, 2011, 2011: 30-35.
  • 2Wei X, Ju X, Yi X, et al. Identification of sequence variants in genetic disease-causing genes using targeted nexbgeneration sequencing. PLoS One, 2011, 6: e29500.
  • 3Smith BC. McAndrew T. Chen Z, et al. The cervical microbiome over 7 years and a comparison of methodologies for its characterization. PLoS One, 2012, 7: e40425.
  • 4Faas BH, de Ligt J, Janssen I, et al. Non-invasive prenatai diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cells. Expert Opin Biol Ther, 2012, 12 Suppi 1:S19-S26.
  • 5Bell C J, Dinwiddie DL, Miller NA, et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med, 2011, 3: 65ra4.
  • 6Luo H, Sun C, Sun Y, et al. Analysis of the transcriptome of Panax notoginseng root uncovers putative triterpene saponin- biosynthetic genes and genetic markers. BMC Genomics, 2011, 12 Suppl 5: S5.
  • 7Ozretic L, Heukamp LC, Odenthal M, et al. The role of molecular diagnostics in cancer diagnosis and treatment. Onkologie, 2012, 35 Suppl 1: 8-12.
  • 8Marchetti A, Del GM, Filice G, et al. Complex mutations & subpopulations of deletions at exon 19 of EGFR in NSCLC revealed by next generation sequencing: potential clinical implications. PLoS One, 2012, 7: e42164.
  • 9Hui P. Next generation sequencing: chemistry, technology and applications. Top Curr Chem, 2012 May 31. [Epub ahead of print].
  • 10Yang D, Khan S, Sun Y, et al. Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. JAMA, 2011, 306: 1557-1565.

共引文献6

同被引文献299

引证文献27

二级引证文献223

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部